Weilin Jin

11.3k citations
213 papers · 8.1k indexed · 5 hit papers · h-index 45

Impact in

Papers in

Weilin Jin

201 papers receiving 8.0k citations

Hit Papers

Drug repurposing for cancer therapy 2024 · 168 citations
1682020202620222024250500750

Peers

Weilin Jin
Comparison fields: 5 of 160
  • Cancer Research 1.9k
  • Developmental Neuroscience 337
  • Molecular Biology 4.4k
  • Oncology 1.6k
  • Immunology 1.0k
Replace Ratna K. Vadlamudi with:
Ratna K. Vadlamudi United States
Angela Bachi Italy
Shih‐Hwa Chiou Taiwan
Min Wang China
Ching C. Lau Hong Kong
Martin Irmler Germany
Jun Qin China
Jian Chen China
Carol J. Thiele United States
Jin Zhang China
Weilin Jin relative to Ratna K. Vadlamudi United States Ratna K. Vadlamudi's profile →
Citations per field
00.5×3.6×
Ratna K. Vadlamudi · 1×
Citations per year

Countries citing papers authored by Weilin Jin

Since Specialization
Citations

This map shows the geographic impact of Weilin Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilin Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilin Jin more than expected).

Fields of papers citing papers by Weilin Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weilin Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilin Jin. The network helps show where Weilin Jin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weilin Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weilin Jin Line = papers co-authored together Weilin Jin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20252
3 20250
4 20253
5 20250
6 20253
7 20240
8 20243
9 20249
10 202411
11 202418
12 20235
13 202311
14 20235
15 202158
16 202135
17 20213
18 20218
19 201844
20 201612

About Weilin Jin

Weilin Jin is a scholar working on Developmental Neuroscience, Cancer Research, Molecular Biology, Neurology and Cellular and Molecular Neuroscience, having authored 213 papers that have together received 8.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (23 papers), RNA modifications and cancer (19 papers), MicroRNA in disease regulation (15 papers), Ubiquitin and proteasome pathways (14 papers), Nerve injury and regeneration (12 papers), Ferroptosis and cancer prognosis (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Cancer Research (1.9k citations), Developmental Neuroscience (337 citations), Molecular Biology (4.4k citations), Oncology (1.6k citations) and Immunology (1.0k citations). Weilin Jin has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xiao‐Yuan Mao, Daxiang Cui, Bairong Xia, Xingchun Gao, Mingzhu Jin, Hualin Fu, Hong‐Hao Zhou, Yajing Mi, Chang Yang and Guanzhong Qiu. Their work appears in journals such as Oncotarget, Frontiers in Immunology, Cellular and Molecular Neurobiology, Frontiers in Oncology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026